News | July 16, 2022
Indian pharmaceutical companies to grow by 6-7% in FY2023: ICRA
ICRA expects the OPM of the sample set to moderate to 20.2% in FY2023 from 21.5% in FY2022.
ICRA expects the OPM of the sample set to moderate to 20.2% in FY2023 from 21.5% in FY2022.
Revenues from operations for the full year ended March 31, 2022 stood at Rs. 590.05 crore as compared to Rs. 449.82 crore in FY21
Cantourage introduces second Clever Leaves medical cannabis product to the German market
The company has posted net profit of Rs.39.71 crores for the Financial Year ended March 31, 2022.
The company has posted net profit of Rs.165.66 crores for the Financial Year ended March 31, 2022
The company has posted net loss of Rs. 67.65 crores for the Financial Year ended March 31, 2022
The company’s annual sales grew from Rs 548.12 crore in FY 2020-21 to Rs 598.65 crore this fiscal
The company has posted net loss of Rs. 460.21 crores for the Financial Year ended March 31, 2022.
The company has posted net profit of Rs.605.05 crores for the Financial Year ended March 31, 2022
The company has posted net profit of Rs.884.08 crores for the Financial Year ended March 31, 2022.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
